250 related articles for article (PubMed ID: 16607618)
1. Photodynamic therapy: combined modality approaches targeting the tumor microenvironment.
Gomer CJ; Ferrario A; Luna M; Rucker N; Wong S
Lasers Surg Med; 2006 Jun; 38(5):516-21. PubMed ID: 16607618
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
Ferrario A; Fisher AM; Rucker N; Gomer CJ
Cancer Res; 2005 Oct; 65(20):9473-8. PubMed ID: 16230411
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice.
Makowski M; Grzela T; Niderla J; ŁAzarczyk M; Mróz P; Kopeé M; Legat M; Strusińska K; Koziak K; Nowis D; Mrówka P; Wasik M; Jakóbisiak M; Gołab J
Clin Cancer Res; 2003 Nov; 9(14):5417-22. PubMed ID: 14614028
[TBL] [Abstract][Full Text] [Related]
5. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib.
Ferrario A; Lim S; Xu F; Luna M; Gaffney KJ; Petasis NA; Schönthal AH; Gomer CJ
Cancer Lett; 2011 May; 304(1):33-40. PubMed ID: 21339042
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 expression induced by photofrin photodynamic therapy involves the p38 MAPK pathway.
Luna M; Wong S; Ferrario A; Gomer CJ
Photochem Photobiol; 2008; 84(2):509-14. PubMed ID: 18282182
[TBL] [Abstract][Full Text] [Related]
9. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.
Chen B; Roskams T; de Witte PA
Lasers Surg Med; 2002; 31(3):158-63. PubMed ID: 12224088
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy and anti-tumor immunity.
Gollnick SO; Owczarczak B; Maier P
Lasers Surg Med; 2006 Jun; 38(5):509-15. PubMed ID: 16788921
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.
Solban N; Selbo PK; Sinha AK; Chang SK; Hasan T
Cancer Res; 2006 Jun; 66(11):5633-40. PubMed ID: 16740700
[TBL] [Abstract][Full Text] [Related]
12. Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth.
deCarvalho AC; Zhang X; Roberts C; Jiang F; Kalkanis SN; Hong X; Lu M; Chopp M
Glia; 2007 Aug; 55(10):1053-60. PubMed ID: 17551928
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model.
Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
Lasers Surg Med; 2011 Sep; 43(7):651-62. PubMed ID: 22057493
[TBL] [Abstract][Full Text] [Related]
14. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
[TBL] [Abstract][Full Text] [Related]
15. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
Ohtani K; Usuda J; Ichinose S; Ishizumi T; Hirata T; Inoue T; Maehara S; Imai K; Kubota M; Tsunoda Y; Yamada M; Tsutsui H; Yamada K; Kuroiwa Y; Furukawa K; Okunaka T; Kato H
Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly.
Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N
Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245
[TBL] [Abstract][Full Text] [Related]
17. Interaction of photodynamic therapy and hyperthermia: tumor response and cell survival studies after treatment of mice in vivo.
Henderson BW; Waldow SM; Potter WR; Dougherty TJ
Cancer Res; 1985 Dec; 45(12 Pt 1):6071-7. PubMed ID: 4063964
[TBL] [Abstract][Full Text] [Related]
18. Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness.
Ferrario A; Luna M; Rucker N; Wong S; Gomer CJ
Lasers Surg Med; 2011 Sep; 43(7):644-50. PubMed ID: 22057492
[TBL] [Abstract][Full Text] [Related]
19. Effects of photodynamic therapy on tumor stroma.
Peng Q; Nesland JM
Ultrastruct Pathol; 2004; 28(5-6):333-40. PubMed ID: 15764581
[TBL] [Abstract][Full Text] [Related]
20. Targeting the tumor microenvironment using photodynamic therapy combined with inhibitors of cyclooxygenase-2 or vascular endothelial growth factor.
Ferrario A; Gomer CJ
Methods Mol Biol; 2010; 635():121-32. PubMed ID: 20552344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]